Idorsia Pharmaceuticals Us Inc

PA · United States · Reporting entity ID 100001171891

Total reported 2019–2025

$12.0M

#442 of 2,960 reporting companies — 0% of all reported industry payments

$7.37M in general payments across 117,155 records, plus $4.66M in research funding across 541 records.

How it breaks down

General payments $7,371,134

Research funding $4,657,229

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.